To confirm that ID4 methylation was associated with disease progression in CML, ID4 methylation was further detected in five follow‐up paired CML patents from earlier to later clinical stage. The gene discussed is ID4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.